跳至主要内容
临床试验/NCT02097537
NCT02097537已完成3 期

Study of Methacholine Chloride Inhalation Challenge in Children With Bronchial Asthma

Santen Pharmaceutical Co., Ltd.1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2014年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
10
试验地点
1
主要终点
The Rate of Number of Subjects Whose PC20 is Less Than 8 mg/mL

研究概览

简要总结

The Purpose of this study is to evaluate the safety and efficacy of SK-1211 inhalation challenge in children with bronchial asthma.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
6 Years 至 15 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of bronchial asthma
  • FEV1/FVC must be 70% or more
  • <10% decrease in FEV1 in response to inhalation of normal saline

排除标准

  • Moderate or severe airflow limitation(FEV1<60% predicted)
  • Heart attack or stroke in last 3 months
  • Uncontrolled hypertension, systolic BP>200, or diastolic BP>100
  • known aortic aneurysm

研究组 & 干预措施

Methacholine Chloride

Experimental

children with bronchial asthma

干预措施: Methacholine Chloride (SK-1211) (Drug)

结局指标

主要结局

The Rate of Number of Subjects Whose PC20 is Less Than 8 mg/mL

时间窗: Visit 1 (Day 1)

The methacholine challenge test is for assessment of bronchial sensitivity, it is assessed by FEV1 (Forced Expiratory Volume in one second) with spirometer. For measurement of FEV1, a patient is inhaled saline as baseline and each dose of methacholine which be gradually diluted, inhalations are discontinued with a drop in FEV1 of 20% or more. The concentration of methacholine causing 20% fall in FEV1 is PC20.

次要结局

  • The Rate of Subjects Whose FEV1 Falls More Than 20% From Baseline Before the Highest Concentration Inhalation(Visit 1 (Day 1))
  • The Summary Statistics of PC20(Visit 1 (Day 1))

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Study of Methacholine Chloride Inhalation Challenge... | 临床试验